OpenURL Connection Search

Select item for more details and to access through your institution.

The Efficacy and Tolerability of Risedronate Once a week for the Treatment of Postmenopausal Osteoporosis.
Published in:
Calcified Tissue International, 2002, v. 71, n. 2, p. 103, doi. 10.1007/s00223-002-2011-8
By:
- Brown, J. P.;
- Kendler, D. L.;
- McClung, M. R.;
- Emkey, R. D.;
- Adachi, J. D.;
- Bolognese, M. A.;
- Li, Z.;
- Balske, A.;
- Lindsay, R.
Publication type:
Article
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates.
Published in:
2016
By:
- Miller, P D;
- Pannacciulli, N;
- Brown, J P;
- Czerwinski, E;
- Nedergaard, B S;
- Bolognese, M A;
- Malouf, J;
- Bone, H G;
- Reginster, J-Y;
- Singer, A;
- Wang, C;
- Wagman, R B;
- Cummings, S R
Publication type:
journal article
Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.
Published in:
2011
By:
- Peacock, Munro;
- Bilezikian, J P;
- Bolognese, M A;
- Borofsky, Michael;
- Scumpia, Simona;
- Sterling, L R;
- Cheng, Sunfa;
- Shoback, Dolores
Publication type:
journal article
Endovascular therapy outcome in isolated posterior cerebral artery occlusion strokes: A multicenter analysis of the Swiss Stroke Registry.
Published in:
European Stroke Journal, 2023, v. 8, n. 2, p. 575, doi. 10.1177/23969873221150125
By:
- Maulucci, F;
- Disanto, G;
- Bianco, G;
- Pileggi, M;
- Fischer, U;
- Padlina, G;
- Strambo, D;
- Michel, P;
- Kahles, T;
- Nedeltchev, K;
- Fisch, U;
- Bonati, L;
- Kägi, G;
- Escribano Paredes, JB;
- Carrera, E;
- Nyffeler, T;
- Bolognese, M;
- Wegener, S;
- Luft, A;
- Schelosky, L
Publication type:
Article
Effects of arzoxifene on bone mineral density and endometrium in postmenopausal women with normal or low bone mass.
Published in:
2009
By:
- Bolognese, M;
- Krege, J H;
- Utian, W H;
- Feldman, R;
- Broy, S;
- Meats, D L;
- Alam, J;
- Lakshmanan, M;
- Omizo, M
Publication type:
journal article
Effect of Denosumab on Bone Density and Turnover in Postmenopausal Women with Low Bone Mass After Long-Term Continued, Discontinued, and Restarting of Therapy: A Randomized Blinded Phase 2 Clinical Trial.
Published in:
From the World of Osteoporosis / Turkiye Osteoporoz Dunyasindan, 2008, v. 14, n. 2, p. 49
By:
- Miller, P. D.;
- Bolognese, M. A.;
- Lewiecki, E. M.;
- McClung, M. R.;
- Ding, B.;
- Austin, M.;
- Liu, Y.;
- San Martin, J.
Publication type:
Article
A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab.
Published in:
Osteoporosis International, 2020, v. 31, n. 11, p. 2231, doi. 10.1007/s00198-020-05502-0
By:
- McClung, M. R.;
- Bolognese, M. A.;
- Brown, J. P.;
- Reginster, J.-Y.;
- Langdahl, B. L.;
- Maddox, J.;
- Shi, Y.;
- Rojeski, M.;
- Meisner, P. D.;
- Grauer, A.
Publication type:
Article
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate
Published in:
Osteoporosis International, 2014, v. 25, n. 7, p. 1953, doi. 10.1007/s00198-014-2692-7
By:
- Brown, J.;
- Roux, C.;
- Ho, P.;
- Bolognese, M.;
- Hall, J.;
- Bone, H.;
- Bonnick, S.;
- Bergh, J.;
- Ferreira, I.;
- Dakin, P.;
- Wagman, R.;
- Recknor, C.
Publication type:
Article
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.
Published in:
Osteoporosis International, 2014, v. 25, n. 5, p. 1439, doi. 10.1007/s00198-014-2655-z
By:
- Siris, E.;
- Adler, R.;
- Bilezikian, J.;
- Bolognese, M.;
- Dawson-Hughes, B.;
- Favus, M.;
- Harris, S.;
- Jan de Beur, S.;
- Khosla, S.;
- Lane, N.;
- Lindsay, R.;
- Nana, A.;
- Orwoll, E.;
- Saag, K.;
- Silverman, S.;
- Watts, N.
Publication type:
Article
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial.
Published in:
Osteoporosis International, 2013, v. 24, n. 1, p. 227, doi. 10.1007/s00198-012-2052-4
By:
- Mcclung, M.;
- Lewiecki, E.;
- Geller, M.;
- Bolognese, M.;
- Peacock, M.;
- Weinstein, R.;
- Ding, B.;
- Rockabrand, E.;
- Wagman, R.;
- Miller, P.
Publication type:
Article
Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet.
Published in:
Osteoporosis International, 2012, v. 23, n. 1, p. 267, doi. 10.1007/s00198-011-1791-y
By:
- McClung, M. R.;
- Miller, P. D.;
- Brown, J. P.;
- Zanchetta, J.;
- Bolognese, M. A.;
- Benhamou, C. L.;
- Balske, A.;
- Burgio, D. E.;
- Sarley, J.;
- McCullough, L. K.;
- Recker, R. R.
Publication type:
Article

Found: 11